At the end of 2019, a new disease—COVID-19—was identified, and a few months later, the World Health Organization announced a pandemic. It is now known that SARS-CoV-2 is highly contagious and most confirmed infections are mild to moderate. The situation is particularly difficult for dentists due to the high risk of virus transmission in the dental surgery. Complications including, but not limited to, problems with the respiratory and cardiovascular systems have been reported in patients with SARS-CoV-2. Several changes in the coagulation system, such as lower platelet numbers or increased prothrombin time, as well as increased D-dimer and fibrinogen, were observed. This review is intended to systematize the knowledge on the treatment of patients with congenital bleeding disorders (CBD) during the SARS-CoV-2 pandemic. Extensive literature research was conducted into COVID-19 and the general medical and dental treatment of patients with CBD. Case studies, research results and recommendations of international societies were used in the study. The results of this research are presented in the form of recommendations for the treatment of patients with coagulopathies. It should be remembered that the impact of COVID-19 on the health condition of patients with CBD is unknown to date.
【저자키워드】 COVID-19, severe acute respiratory syndrome coronavirus 2, cardiovascular system, Pandemics, dentists, blood coagulation disorders, 【초록키워드】 Treatment, SARS-CoV-2, pandemic, knowledge, Infection, D-dimer, virus transmission, International, Research, Patient, Platelet, Complication, Mild, fibrinogen, Coagulation system, Coagulopathies, moderate, high risk, Prothrombin time, World Health Organization, dentist, problem, contagious, health condition, recommendation, reported, conducted, were used, changes in, bleeding disorder, Extensive, patients with SARS-CoV-2, the SARS-CoV-2, 【제목키워드】 review, dental, congenital, narrative,